Influence of probes for calcium-calmodulin and protein kinase C signalling on the plasma membrane Ca2+-ATPase activity of rat synaptosomes and leukocyte membranes

Immunopharmacology

Volumn 40, Issue 2, 1998, Pages 163-171

  Grosman, Nina ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antineoplastic ether phospholipids; Calmodulin inhibitors; Plasma membrane Ca2+ ATPase activity; Protein kinase C inhibitors; Rat brain synaptosomes; Rat leukocyte membranes; Sphingosine

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM; CALCIUM CHLORIDE; CALMODULIN; CALMODULIN INHIBITOR; MIDOSTAURIN; MILTEFOSINE; PHOSPHOLIPID; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; QUERCETIN; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CALCIUM CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; LEUKOCYTE MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM-TRANSPORTING ATPASES; CALMODULIN; CELL MEMBRANE; ENZYME INHIBITORS; GALLIC ACID; IMIDAZOLES; LEUKOCYTES; MALE; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE; PROTEIN KINASE C; QUERCETIN; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SPHINGOSINE; STAUROSPORINE; SYNAPTOSOMES;

EID: 0031757589     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00042-3     Document Type: Article

References (39)

1. 2+-ATPase by acidic phospholipids and by controlled proteolysis. FEBS Lett. 143:1982;65-68.
2. 2+ concentration in a normal and a breast cancer cell line. Anticancer Res. 14:1994;1549-1556.
3. Brachwitz H., Vollgraf C. Analogues of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacol. Ther. 66:1995;39-82.
4. Carafoli E. Biogenesis: plasma membrane calcium ATPase: 15 years of work on the purified enzyme. FASEB J. 8:1994;993-1002.
5. 2+) ATPase activity and fluidity of the synaptosomal membrane. Pharmacology and Toxicology. 67:1990;56-60.
6. 2+ pump contains a site that interacts with its calmodulin-binding domain. J. Biol. Chem. 266:1991;2930-2936.
7. Gietzen, K., 1986. Pharmacological regulation of the activity of calmodulin. In: Bader, H., Gietzen, K., Rosenthal, J., Rüdel, R., Wolf, H.U. (Eds.), Intracellular Calcium Regulation. Manchester Univ. Press, pp. 405-423.
8. 2+-transport ATPase and of calmodulin-regulated functions. Biochem. Biophys. Res. Commun. 101:1981;418-425.
9. Grosman N. Effect of calmidazolium (R24571) on histamine release from isolated rat mast cells. Agents and Actions. 17:1985;427-435.
10. Grosman N. Inhibitory effect of phloretin on histamine release from isolated rat mast cells. Agents and Actions. 25:1988;284-290.
11. Grosman N. Sphingosine inhibition and promotion of histamine release from isolated rat mast cells. Agents and Actions. 31:1990;171-177.
12. Grosman N. Effects of the ether phospholipid AMG-PC on mast cells are similar to that of the ether lipid AMG but different from that of the analogue hexadecylphosphocholine. Immunopharmacology. 22:1991;39-48.
13. Grosman N. Influence of CGS 9343B, an inhibitor of calmodulin activity, on histamine release from isolated rat mast cells. Agents and Actions. 36:1992;192-199.
14. Grosman N. Influence of staurosporine, a more selective derivative CGP 41251 and an inactive analogue CGP 42700 on histamine release from isolated rat mast cells. Immunopharmacology. 24:1992;47-56.
15. Hannun Y.A., Linardic C.M. Sphingolipid breakdown products: antiproliferative and tumour-suppressor lipids. Biochim. Biophys. Acta. 1154:1993;223-236.
16. 3. Leuk. Res. 19:1995;417-425.
17. Hilgard P., Klenner T., Stekar J., Unger C. Alkylphosphocholines: a new class of membrane-active anticancer agents. Cancer Chemother. Pharmacol. 32:1993;90-95.
18. Houlihan W.J., Lohmeyer M., Workman P., Cheon S.H. Phospholipid antitumour agents. Med. Res. Rev. 15:1995;157-223.
19. Jefferson A.B., Schulman H. Sphingosine inhibits calmodulin-dependent enzymes. J. Biol. Chem. 263:1988;15241-15244.
20. Kolesnick R.N. Sphingomyelin and derivatives as cellular signals. Prog. Lipid Res. 30:1991;1-38.
21. Lambeth J.D., Burnham D.N., Tyagi S.R. Sphinganine effects on chemoattractant-induced diacylglycerol generation, calcium fluxes, superoxide production, and on cell viability in the human neutrophil: delivery of sphinganine with bovine serum albumin minimizes cytotoxicity without affecting inhibition of the respiratory burst. J. Biol. Chem. 263:1988;3818-3822.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. 2+-dependent protein kinase inhibition by R24571, a calmodulin antagonist. Biochem. Pharmacol. 33:1984;125-130.
24. Merrill A.H., Schmelz E-M., Dillehay D.L., Spiegel S., Shayman J.A., Schroeder J.J., Riley R.T., Voss K.A., Wang E. Symposium: sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142:1997;208-225.
25. Middleton E., Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 43:1992;1167-1179.
26. 3 and BM 41.440. Biochem. Biophys. Res. Commun. 157:1988;1000-1006.
27. Oishi K., Zheng B., Kuo J.F. Inhibition of Na, K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid. J. Biol. Chem. 265:1990;70-75.
28. 2+ stores in the pancreatic acinar cell. Biochim. Biophys. Acta. 1195:1994;45-50.
29. 2+-ATPase by two calmodulin antagonists. Biochem. Pharmacol. 43:1992;1797-1803.
30. 2+ pump: recent developments. Cell Physiol. Biochem. 4:1994;148-159.
31. Powis G. Signalling pathways as targets for anticancer drug development. Pharmacol. Ther. 62:1994;57-95.
32. Robak J., Gryglewski R.J. Bioactivity of flavonoids. Pol. J. Pharmacol. 48:1996;555-564.
33. Spiegel S., Milstien S. Sphingolipid metabolites: members of a new class of lipid second messengers. J. Membrane Biol. 146:1995;225-237.
34. 2+ pump: kinetics and structure-function relationships. Biochem. Pharmacol. 41:1991;669-675.
35. Van Belle H. The effect of drugs on calmodulin and its interaction with phosphodiesterase. Adv. Cyclic Nucleotide Protein Phosphoryl. Res. 17:1984;557-567.
36. 2+ concentrations of human neutrophils. Biochem. J. 283:1992;499-505.
37. 2+-transport system of the endoplasmic reticulum. Cell Calcium. 6:1985;295-310.
38. 2+-transport ATPases from the plasma membrane. J. Bioenerg. Biomembr. 24:1992;285-300.
39. Zheng B., Oishi K., Shoji M., Eibl H., Berdel W.E., Hajdu J., Vogler W.R., Kuo J.F. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res. 50:1990;3025-3031.